BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue R, Hua L, Xu W, Gao Y, Pang Y, Hao J. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk. Biomed Res Int 2018;2018:4283673. [PMID: 30519576 DOI: 10.1155/2018/4283673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Xue R, Zhou J, Wu J, Meng Q, Gong J, Shen L. P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway. Dig Dis Sci 2022. [PMID: 36002675 DOI: 10.1007/s10620-022-07605-6] [Reference Citation Analysis]
2 Su L, Liu G, Guo Y, Zhang X, Zhu X, Wang J. Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes. Front Genet 2022;13:854661. [PMID: 35711911 DOI: 10.3389/fgene.2022.854661] [Reference Citation Analysis]
3 Chen L, Lin YH, Liu GQ, Huang JE, Wei W, Yang ZH, Hu YM, Xie JH, Yu HZ. Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases. Front Genet 2021;12:804916. [PMID: 35096017 DOI: 10.3389/fgene.2021.804916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ta HDK, Wang WJ, Phan NN, An Ton NT, Anuraga G, Ku SC, Wu YF, Wang CY, Lee KH. Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer. Cancers (Basel) 2021;13:4902. [PMID: 34638387 DOI: 10.3390/cancers13194902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yin J, Lin C, Jiang M, Tang X, Xie D, Chen J, Ke R. CENPL, ISG20L2, LSM4, MRPL3 are four novel hub genes and may serve as diagnostic and prognostic markers in breast cancer. Sci Rep 2021;11:15610. [PMID: 34341433 DOI: 10.1038/s41598-021-95068-6] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Pang TCY, Xu Z, Mekapogu AR, Pothula S, Becker T, Corley S, Wilkins MR, Goldstein D, Pirola R, Wilson J, Apte M. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Cancers (Basel) 2021;13:2763. [PMID: 34199452 DOI: 10.3390/cancers13112763] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Hou W, Zhang Y. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184. Pathol Res Pract 2021;217:153275. [PMID: 33285422 DOI: 10.1016/j.prp.2020.153275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dey S, Liu S, Factora TD, Taleb S, Riverahernandez P, Udari L, Zhong X, Wan J, Kota J. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment. BMC Cancer 2020;20:651. [PMID: 32660466 DOI: 10.1186/s12885-020-07135-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]